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Isolates of atypical scrapie recently identified in sheep
and goats in France were compared with Nor98 isolates
reported in Norway. Western blot methods for characteriza-
tion of the protease-resistant prion protein showed that all
these isolates shared a unique biochemical signature: 5
groups of bands, including a characteristic band of appar-
ent low molecular weight (11 kDa). This pattern could orig-
inate from the presence of 3 different protease cleavage
products, including the 11 kDa most likely cleaved at both
N- and C-sides of the protein. Genetic data, which strongly
suggested the higher susceptibility of AHQ and AF141RQ
animals in French cases, resembled earlier data from
Nor98 scrapie. 
T
ransmissible spongiform encephalopathies (TSEs) are
neurodegenerative disorders that occur in sheep and
goats (scrapie), cattle (bovine spongiform encephalopathy
[BSE]), or humans (Creutzfeldt-Jakob disease). The bio-
chemical marker of the disease is currently considered to
be the accumulation of an abnormal isoform (PrPres) of
the normal cellular prion protein (PrPc). PrPres can be
identified by its partial resistance to proteases and insolu-
bility in detergents. Classically, after pK treatment and
Western blot (WB), PrPres exhibits a typical 3-band pat-
tern comprising 18–30 kDa, whereas PrPc is totally digest-
ed (1,2).
Ovine susceptibility to scrapie is largely controlled by
polymorphisms at the PrP gene (prnp). The major poly-
morphisms associated with susceptibility or resistance are
located at codons 136 (A or V), 154 (R or H), and 171 (R,
Q, or H) (3,4). V136R154Q171/VRQ, ARQ/VRQ, and ARQ/
ARQ PrP animals are considered the most susceptible to
scrapie, whereas homozygous or heterozygous AHQ and
heterozygous ARR animals show only marginal suscepti-
bility (5). ARR/ARR sheep are considered to be the more
resistant (4,6), but after oral challenge with BSE agent they
can accumulate PrPres in the spleen (7).
In 1998, a novel and unusual TSE type (called Nor98)
was identified in sheep in Norway (8). A large proportion
of animals were carriers of AHQ and AF141RQ alleles (9).
The PrP WB signature in these cases differed from the
known scrapie profile; the classic 3-band WB pattern was
replaced by a multiband pattern with a prominent band of
low molecular mass (≈12 kDa).
Since 2002, an active surveillance program for TSE
has been implemented in small ruminants in European
Union (EU) countries. As a result of this program, unusu-
al TSE isolates were rapidly identified in sheep and goats
in France, Germany (10,11), and Great Britain (12). These
atypical TSE isolates had the following characteristics:
1) they came from sheep carrying PrP alleles reportedly
associated with resistance to TSEs; 2) their rapid diagnos-
tic test results based on PrPres detection showed discrep-
ancies; and 3) they could not be readily confirmed by
recommended Office International des Epizooties diagnos-
tic methods (10). In this study we investigated a panel of
54 French atypical isolates from sheep (n = 51) and goats
(n = 3) and compared their PrP genotypes and advanced
PrPres biochemical signatures (WB electrophoretic mobil-
ity, epitope mapping, and PrPres deglycosylation pattern)
with those of Nor98 cases.
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Materials and Methods
Small Ruminant Isolates
The biologic samples (Table) consisted of 54 brain
stems from 51 sheep from France and 3 goats previously
classified as having atypical scrapie and collected during
the active surveillance program between 2002 and 2004.
These samples were compared with Nor98 samples from 4
Norwegian sheep.
The  prnp polymorphisms from these atypical cases
were compared with a panel from animals with classic
scrapie (74 clinically affected sheep obtained from 60
flocks between 2000 and 2002 and 60 scrapie-positive
goats obtained from 13 flocks between 2002 and 2004. The
animals with classic scrapie were not matched for age,
breed, or flock structure with animals with atypical scrapie.
prnp ORF Sequencing
In each case, DNA was directly recovered from brain
stem (30 mg) by using a commercial DNA extraction kit
(Qiaprep DNeasy Minikit (QIAGEN, Courtaboeuf,
France) according to manufacturer’s recommendations.
The complete open reading frame (ORF) sequence of the
prnp gene was determined by sequencing both strands of 2
overlapping PCR fragments covering the complete ovine
prnp ORF (primer 1F: GTGGGCATTTGATGCTGACAC,
primer 1R: TGGTTGGGGTAACGGTACATG, Tm1 59°C,
primer 2F: TCAGCCCCATGGTGGTGGCT, primer 2R:
CTGCAGGTAGACACTCCCTCC, Tm2 61°C). The same
primers were used for the goat samples.
The PCR products were amplified for 35 cycles
(extension time 45 s) and allowed to migrate on 1%
agarose gel. They were then purified, and both strands
were sequenced. The appropriate software (SemanII,
DNAstar, Monluçon, France) was then used to reconstitute
the ORF sequence and align it with reference sequences
from both ovine and caprine species.
PrPres Purification and Western Blotting
Samples were examined by TeSeE WB (Bio-Rad,
Marnes la Coquette, France), according to manufacturer’s
recommendations. Briefly, 20% brain homogenate was
incubated with pK and detergent solution for 10 min at
37°C before buffer B was added. Samples were then cen-
trifuged at 15,000× g for 7 min and the pellet solubilized
by incubation at 100°C for 5 min in 100 µL Laemmli solu-
tion completed (Bio-Rad) with 5% (v/v) β-mercap-
toethanol and 2% (w/v) sodium dodecyl sulfate (SDS).
Samples were centrifuged at 15,000× g for 15 min. The
supernatants were then heated at 100°C for 5 min and sub-
jected to electrophoresis. The undiluted sample (equivalent
to 15 mg of tissue) was loaded onto homemade acrylamide
SDS-polyacrylamide gels.
Gels (15% resolving gel and 4% stacking gel) were
subjected to electrophoresis for 60 min at 200 V. The pro-
teins were transferred onto a polyvinylidene difluoride
membrane at 115 V for 60 min. The membrane was soaked
successively with phosphate-buffered saline (PBS),
ethanol, and distilled water; saturated with blocking solu-
tion for 30 min; and then incubated for 30 min at room
temperature with Sha 31 (4 µg/mL in PBS-Tween [PBST])
against the YEDRYYRE (148–155) ovine PrP sequence
(13). The membrane was then washed with PBST and
incubated for 20 min with goat anti-mouse immunoglobu-
lin G (IgG) antibody conjugated with horseradish peroxi-
dase diluted 1:10 in PBST. It was the subjected to theRESEARCH
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enhanced chemiluminescence WB detection (Amersham
or Supersignal, Pierce, Orsay, France) and visualized by
using the Versa Doc image analysis system (Bio-Rad).
MW Determination
A panel of 20 of these samples from 17 French sheep
with atypical cases, 2 French goats with atypical cases, and
a Norwegian sheep with Nor98 (Table) were selected for
detailed molecular characterization. The apparent molecu-
lar weights (MWs) were determined with a protein stan-
dard (B2787; Sigma, Saint Louis, MO, USA). Each band
was measured (apparent MWs and proportions) by using
Quantity One software (Bio-Rad).
Epitope Mapping
Different monoclonal antibodies (MAbs) were used
for detection of PrPres fragments: Sha 31 (4 µg/mL in
PBST), P4 (1/2,500 in PBST) (R-Biopharm, Saint-Didier
Au Mont d’Or, France), 4F2 (1/2,500 in PBST), and
99/97.6.1 (1/2,500 in PBST). They recognized the follow-
ing respective ovine sequences: YEDRYYRE (148–155)
(13), WGQGGSH (93–99) (14),QPHGGGW (62–93), and
99/97.6.1 YQRE (221–224) (J. Langeveld, unpub. Pepscan
data). The membranes were washed and then incubated
with peroxidase-labeled conjugates against mouse Ig
(1/2,500 in PBST) (Ozyme, Saint Quentin/Yvelines,
France).
Deglycosylation Experiments
Deglycosylation experiments were performed on 6
French and 1 Nor98 isolates with PNGaseF, following the
Ozyme manufacturer’s instructions (P0704S) and TeSeE
WB protocol for sample purification. Briefly, after PrPres
purification, the pellet was solubilized by incubating at
100°C for 10 min in glycoprotein denaturing buffer 1×
instead of Laemmli (Bio-Rad) solution. Samples were
treated with PNGase F for 1 h at 37°C (reaction buffer 1×,
10% NP-40, PNGase F); buffer B was then added.
Samples were centrifuged at 15,000× g for 7 min, and the
pellets were solubilized in 100 µL completed Laemmli
solution by incubation at 100°C for 5 min. Samples were
then centrifuged at 15,000× g for 15 min, and the super-
natants were heated at 100°C for 5 min before elec-
trophoresis.
Results
All the atypical cases detected in France by the sur-
veillance program were initially identified by an ELISA
rapid diagnosis test (TeSeE Bio-Rad). The brain stem sam-
ples in our atypical scrapie panel (n = 54) invariably gave
negative results with modified SAF (Scrapie-associated
fibrils) Immunoblot (10,15). However, the 51 sheep and 3
goat isolates analyzed gave positive results with the
highly sensitive WB method (TeSeE Bio-Rad), which used
the classic pK concentration for sample digestion and
Sha31 MAb for PrPres detection.
PrP Genetics of Classic and Atypical Cases
The prnp genotypes at codons 136, 141, 154, and 171
are shown in the Table. Most (87.8%) samples from sheep
with classic scrapie were observed in genotypes with com-
binations of the ARQ, ARH, and VRQ alleles. Asmall pro-
portion (12%) of classic scrapie cases were observed in
AF141RQ carriers, but no classic scrapie was found in ani-
mals carrying the AHQ or ARR allele.
A large proportion (82.3%) of animals in the atypical
sheep scrapie group carried the AF141RQ (n = 35, 68.6%)
or AHQ (n = 7, 13.7%) allele. An unusually high propor-
tion of atypical cases were ARR heterozygous (n = 20,
39.2%), but in 16 cases the ARR allele was associated with
either the AF141RQ or AHQ allele. Six of the atypical cases
were ARR/ARR homozygous (11.8%).
Only 3 of the atypical cases had genotypes combining
the ARQ, ARH, and VRQ alleles association, which was
strikingly different from the group of classic sheep scrapie
cases. Similarly, only 4 animals (7.8%) carried the highly
susceptible VRQ allele, and in all cases this was associat-
ed with the AF141RQ allele. Two of the 3 goats with atypi-
cal cases carried the AHQ allele (1 homozygous and 1
heterozygous), whereas none of the 60 sheep with cases of
classic scrapie carried the AHQ allele (Table). Taken
together, these data strongly suggest that AHQ and
AF141RQ animals are more susceptibile to atypical scrapie
than to classic scrapie.
PrPres WB Pattern of Atypical Scrapie 
and Nor98 Isolates
All the atypical isolates showed a complex multiband
pattern that differed dramatically from the 3-band pattern
observed in classic scrapie (Figure 1A, B). Five major
bands (designated I to V according to increasing electro-
mobility) could be distinguished in all atypical cases, irre-
spective of genotype or species (sheep or goat); in all 54
cases, a V band was clearly observed around 11 kDa.
Twenty isolates, from 17 sheep with various geno-
types, 2 goats, and 1 Nor98 sheep (Table), were subjected
to repeated electrophoresis to measure the bands’apparent
form. According to our measurements, the patterns from
the 19 French atypical cases were very similar to each
other and indistinguishable from those from the
Norwegian Nor98 isolate (Figure 1C).
However, a slight variability could be observed in the
apparent MWs between cases. Variations of the WB
method were further examined in repeated runs of PrPres
isolated from a classic scrapie isolate to assess their possi-
ble significance. The analysis of 15 different runs of suchNor98 Cases in France and Norway
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 1, January 2007 61
a sample showed a variation coefficient (standard devia-
tion divided by mean) of 2.1% (±0.1%) for the 3 bands.
The observed variations in the individual measures for
atypical scrapie samples were 2.0% (±1.0%) for bands I to
IV and 4.5% (±3.0%) for band V. These findings strongly
suggest that the observed variations between the different
samples were probably due to the method rather than to
significant differences between samples.
The proportion of total PrPres WB signal represented
by each band in the same panel of 19 French atypical cases
was measured (Figure 1D). Band II was significantly more
intense (mean 35%) than band III (mean 20%) or bands I,
IV, and V (means 10%–15%). Two individual peaks could
be identified in bands II and III in runs and lanes with the
highest resolution. These 2 peaks were located at 28.5
(±0.6) and 26.6 (±0.55) kDa in band II and at 22.5 (±0.8)
and 20.9 (±0.4) kDa in band III (Figure 2, small arrows).
PrPres Deglycosylation and Epitope Mapping
Deglycosylations experiments with PNGase before
WB analysis were then conducted to investigate the origin
of this complex banding pattern. Because of the limited
amount of field-collected material (brain stem only) and
their low PrPres levels, only 6 atypical sheep isolates and
1 Nor98 isolate could be investigated. A similar pattern of
3 bands at 23.0 (±0.5), 17.8 (±0.7), and 10.9 (±0.4) kDa
(referred to as A, B, and C forms, respectively) (Figure 1E)
was observed in all 7 samples. PNGase treatment of clas-
sic scrapie cases resulted in a single band at 19.2 (±0.4)
kDa (Figure 1F), which is consistent with already pub-
lished data.
The biochemical pattern was characterized by epitope
mapping of PrPres using 4F2 (62–93), P4 (93–99), Sha 31
(148–155), and 99/97.6.1 (221–224) (Figure 2). Bands I to
III were strongly recognized by all 4 MAbs in our panel,
which indicated that the 3 bands at least contained the 85–
to 155–amino acid sequence. Band IV was clearly recog-
nized by P4 and Sha31 antibodies and faintly by 4F2 and
99/97.6.1. Band V was not recognized by the more C-ter-
minal 99/97.6.1 antibody, which suggests that this band
corresponds to a C-terminal cleaved PrPres fragment but
was labeled by the 3 other MAbs, although more weakly
by the 4F2 antibody.
Discussion
In this study, we characterized a series of TSE isolates
from French sheep and goats originally classified as hav-
ing atypical scrapie cases (10) on the basis of discrepancies
between rapid diagnostic tests and confirmatory methods
used to detect PrPres in brain stem samples. Similar dis-
Figure 1. Atypical scrapie and Nor98 iso-
lates PrPres Western blot pattern. Western
blot (WB) profile in atypical (A, lane 2) and
classic (B, lane 3) scrapie isolates with
curves of chemiluminescence measured
along the lane and corresponding apparent
MWs (MWs), assessed by Bio-Rad
Quantity One software analysis after signal
capture using Versa Doc5000. Molecular
weight (MW) standard (lanes 1). WB pro-
files of French atypical isolates in sheep (n
= 17) and goats (n = 2) were compared
with those of a Nor98 isolate. Apparent
molecular masses (C) and proportions (D)
of bands I to V were assessed from 3 inde-
pendent runs for each sample by Bio-Rad
Quantity One software analysis after signal
capture using Versa Doc5000. Apparent
MWs are measures for each of the atypical
scrapie isolates, and proportions of bands
are the means and standard deviations in
the 19 atypical scrapie isolates. WB pro-
files of PrPres after PNGase deglycosyla-
tion with curves of chemiluminescence in
atypical (E, lane 4) and classic (F, lane 5)
scrapie isolates. Apparent MWs were esti-
mated by comparison with a MW standard
(lane 1) from 10 independent runs.RESEARCH
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crepancies had been observed in the early description of
so-called Nor98 scrapie isolates (8). The long-debated
hypothesis that atypical cases and Nor98 cases could be
only artifacts and not true TSE was recently ruled out by
the successful transmission of 10 of these French atypical
isolates and 3 Nor98 isolates to transgenic mice overex-
pressing the ovine PrP (V136 R154 Q171 allele) (16).
Similarly, PrPres could be detected by using the TeSeE
Bio-Rad WB method for all the French atypical and Nor98
cases studied here.
Original PrPres WB Signature
We found that PrPres showed a unique biochemical
signature in all cases (54 French atypical and 4 Nor98 iso-
lates) in comparison to classic scrapie, with 1) a multiband
pattern with a characteristic band of low MW (11 kDa) and
2) 3 distinct deglycosylated PrPres forms of  23, 18, and 11
kDa (A, B, and C fragments, respectively). Given the the-
oretical MW of ≈22.8 kDa of the mature ovine PrPprotein,
the results obtained with all 4 antibodies in our panel, and
the C-terminal 99/97.6.1 epitope undetected from only
band V, the following hypothetical sequences of the A, B,
and C fragments can be inferred (Figure 3A ;[17]). The
PrPres fragment A (23 kDa) might correspond to a native
(uncleaved or marginally cleaved by pK treatment) PrP
fragment. The PrPres fragment B could be N terminally
cleaved (nearby 4F2 epitope), as in classic scrapie,
although cleavage of the C-terminal end cannot be fully
excluded. While this scenario is already suggested by the
faint labeling with 99/97.6.1 antibody, it would also be
consistent with the observation that, despite the presence
of the P4 epitope, PrPres B apparently has a lower mass
than PrPres in ovine BSE (18). The C fragment (11 kDa)
could correspond to an N (nearby 4F2 epitope) and C ter-
minally cleaved PrPres protein.
If one assumes that the PrPres glycosylation process
could be similar in classic (+3.8 or +7.9 for monoglycosy-
lation and biglycosylation, respectively) and atypical
scrapie cases, the theoretical MWs of the unglycosylated,
monoglycosylated, and biglycosylated forms that could be
derived from A, B, and C fragments can be reconstituted
and compared with the banding pattern observed with dif-
ferent antibodies, such as Sha31 MAb (Figure 3B).
Glycosylations of the 23-kDa Aform would result in bands
at 26.8 kDa and 30.9 kDa and those of the 18-kDa B form
in bands at 21.6 and 25.7 kDa. These forms are consistent
with bands I to IV, as well as with the presence of 2 distinct
PrP forms detectable in both band II and band III in WB
with the highest resolution (Figure 3B). The absence of
detectable bands at 15 kDa and 19 kDa with any of the
antibodies tested could suggest that the C form would only
be present in the unglycosylated form. This lack of glyco-
sylation would be consistent with a C-terminal cleavage of
this PrP form upstream from the N-glycosylation sites
(amino acids 184 and 200). Taken together, these hypothe-
ses could explain the unique WB pattern identified in all
the French atypical and Nor98 isolates studied here (Figure
3B). However, other hypotheses, such as the existence of
random pK-digested fragments resulting in 3 major PrPres
with variable sequences after deglycosylation, cannot be
fully excluded.
These hypotheses need to be considered in the light of
results recently published by Klingeborn et al. (19). After
purification of PrPres, including a pK treatment at 100
µg/mL for 1 h at 37°C, and concentration by precipitation
with trichloroacetic acid, these authors detected 2 PrPres
Figure 2. Western blot profiles of PrPres in an atypical scrapie isolate (lane 2) detected by using N-terminal (4F2, P4), central (Sha31),
or C-terminal (99/97.6.1) monoclonal antibodies. Molecular weight (MW) standard (lane 1). Immunoreactivities obtained with each anti-
body on 10 different atypical scrapie isolates are indicated (+, strong, ±, low, -, absent).Nor98 Cases in France and Norway
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products at 7 kDa (Nor98-PrP7) and 14 kDa (PrP-CTF14)
in Nor98 case isolates from Swedish sheep. Importantly, 1
of these Swedish Nor98 cases was investigated in a labo-
ratory taking part in this study (that of S.L. Benestad) and
showed the same pattern with the band of low MW at 11
kDa with TeSeE Bio-Rad WB. Differences in the apparent
molecular masses between the isolates from the 2 studies
could result, at least in part, from the different methods
used for PrPres purification and concentration, when one
considers the high pK sensitivity of PrPres in atypical
scrapie (10,12). The choice of antibodies could also con-
tribute to the observed differences. For instance, in our
study, band V consistently showed an apparently lower
molecular mass (9–10 kDa), with P4 antibody (antibody
used in the Klingeborn et al. study). Therefore, fragments
C (11 kDa) and B (18 kDa) could correspond to Nor98-
PrP7 and PrP-CTF14, respectively, in the harsher pK con-
ditions used by Klingeborn et al. PrPres fragment A
(23 kDa) was not observed by Klingeborn et al., which
suggests that this PrPres form might be completely digest-
ed or transformed into fragments of Nor98-PrP7, PrP-
CTF14, or both. Despite minor differences, the results of
the 2 studies in regard to the particular molecular features
of atypical scrapie/Nor98 isolates are consistent.
The presence of a PrPres fragment with an apparently
low molecular mass, which is a salient feature of atypical
and Nor98 cases, has already been reported in several
human diseases. N terminally truncated PrPres migrating
to either 12 kDa or 13 kDa have been reported in some
sporadic Creutzfeldt-Jakob disease cases (20). The identi-
fication of a low-MW fragment cleaved at both C- and N-
terminal ends of the prion protein has even been described
as the hallmark of Gerstmann-Sträussler-Scheinker syn-
drome in humans (2,21–24). However, even if these atyp-
ical isolates appear to have similarities with those from
rare human prion diseases, atypical cases of scrapie are not
rare in sheep and goats and, in some countries, are more
frequent than the classic disease.
Biodiversity in Atypical Cases
The isolates from the 54 atypical cases we investigated
here, which included a large panel of different PrP geno-
types and 2 species (sheep and goat), possessed a unique
biochemical signature, indistinguishable from that of the
Nor98 isolates. All of the isolates from the French atypical
and Nor98 cases that were transmitted to Tg338 ovine
transgenic mice also shared the same biologic signature,
with comparable incubation periods, clinical signs, lesion
profiles, and PrPres deposits patterns in the central nervous
system (16). Moreover, the PrPres biochemical signature in
the inoculated Tg338 was strikingly comparable to that
observed in the present study. Taken together, these data
strongly suggest that the prions involved in atypical (sheep
and goat) and Nor98 cases are in fact a unique TSE agent.
However, because our cases were obtained from only 2
countries, whereas atypical cases have been identified
throughout Europe (12,25–29), further studies are required
before definitive conclusions can be drawn. Nevertheless,
the lack of diversity in our panel, combined with the iden-
tity with Nor98 cases, suggests that the biodiversity of the
TSE agents of atypical scrapie is not large.
Allelic Tropism in Atypical Cases
Although polymorphisms associated with classic
scrapie have been widely documented (4,6), both the atyp-
ical and Nor98 cases (9) seemed to deviate from the estab-
lished concepts of classic scrapie. In our panel, an
obviously high susceptibility seemed to be associated with
the AHQ and AF141RQ alleles, whereas the VRQ allele was
poorly represented. Similar observations were reported for
Nor98 cases (8,9).
Figure 3. A) Schematic representation of ovine PrPc with location
of epitopes recognized by the monoclonal antibodies used during
the study and approaching sizes of PrPres fragments in atypical
scrapie and Nor98 isolates. Theoretical apparent molecular
weights (MWs) of PrP fragments were calculated, by using those
of each amino acid included in the known ARQ sheep PrP
sequence, according to Sambrook and Russell (17). B) Interpre-
tation of PrPres Western blot (WB) profiles in atypical scrapie and
Nor98 isolates. Theoretical WB profile shows the expected appar-
ent molecular masses of glycosylated PrP forms estimated by
addition of 3.8 (*, monoglycosylated) or 7.9 (**, diglycosylated)
kDa to the apparent molecular masses of A and B PrPres forms
observed after PNGaseF deglycosylation. Values of 3.8 and 7.9
kDa were estimated from comparisons of glycosylated and ungly-
cosylated forms in a classic scrapie isolate. The Sha31 WB profile
included the mean apparent MWs assessed from highest resolu-
tion WB analysis (n = 32) and showed 2 separate peaks of maxi-
mal intensity in pictograms of signal intensities of bands II and III
(19 sheep scrapie isolates).RESEARCH
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However, a proper analysis of the risk associated with
each genotype in atypical cases will require much more
data than those presented here. Indeed, all our atypical case
data were collected through active surveillance network,
by using a particular rapid diagnosis test. These affected
animals would need to be matched for breed, age, and pop-
ulation (detection within the same active surveillance pro-
gram with similar tests) to permit an appropriate risk factor
analysis and comparison of susceptibility with animals
with classic scrapie. Moreover, the distribution of F141
within each breed is currently unknown. This work is
ongoing in France, and results should be presented soon.
The involvement of ARR/ARR genotype animals not
only in our study (6 cases) but also in several EU countries
(11,30) is also of some concern. Based on the observed
resistance to TSE in homozygous ARR animals, a breeding
program for resistance to scrapie and BSE has been imple-
mented in several EU countries to control human exposure
to TSE risk. This unusual susceptibility of small ruminants
believed to be genetically resistant to TSE could lead to a
reevaluation of such a policy. In this context, determining
the distribution of infectivity in different tissues of affect-
ed animals and whether or not atypical scrapie is naturally
transmissible between animals within affected flocks
would also be helpful.
Conclusion
Our data provide new information about the recently
described atypical cases of TSE. These cases appear to be
associated with a novel PrPres biochemical pattern; they
shared similarities with some rare prion diseases in
humans and were clearly distinct from classic scrapie or
BSE. This potential similarity in PrPres formation mecha-
nisms with some other rare prion diseases in humans is
intriguing. However, the unusual properties of these atypi-
cal cases illustrate our decades of underestimating the bio-
diversity of TSEs in small ruminants and the
consequences. This finding should lead to a general reex-
amination of our conceptual approach in the control of
TSEs in small ruminants.
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